Russell Newman



HTA - Newman.jpg

Since Russell Newman was appointed to President of HealthTronics at  age 35 (approx. $170M revenue) in February 2014, he lead the successful spinoff of HealthTronics from publicly traded pharmaceutical company Endo International, “Endo” (Nasdaq: ENDP) to Private Equity (Altaris Capital Partners) (2014)

In four years as President of HealthTronics,

·        Revenue has grown more than 20% and profitability of the company has nearly doubled

·        Expanded the company’s service offerings to become a full suite provider of mobile, surgical     solutions

·        Expanded the company’s geographic footprint and technical capabilities with nearly 50% growth in employee base since 2014

Mr. Newman has lead or participated in numerous acquisitions and integrations including HealthTronics acquisition of Endocare, Inc (2009), Endo Pharm $2.6B acquisition of American Medical Systems (AMS, now owned by Boston Scientific) in 2011, and has successfully completed eight acquisitions since 2014

Previously, Mr. Newman served as Vice President and General Manager for HealthTronics' General Urology Solutions, a position which he was appointed to in September 2011. 

Mr. Newman joined HealthTronics in 2008 as a Senior Financial Consultant and was soon promoted to Director of Business Planning & Operations. Prior to joining HealthTronics,

Mr. Newman held various finance positions with Dell, Inc., where he was recognized for his outstanding performance through nominations in the CFO Award program and participation in the CFO Finance Rotation Program.  Prior to Dell, Mr. Newman held positions of increasing responsibility with Arthur Andersen and Property Crossing LLC.

Mr. Newman holds a Bachelor's degree in Business Administration and a Master's degree in Professional Accounting from The University of Texas and is a licensed CPA.